Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.44 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19114877 | 1.00 | LMNA (0.65) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL29302167 | 1.00 | LMNA (0.65) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL18415057 | 1.00 | LMNA (0.65) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4378393 | 1.00 | LMNA (0.65) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL2352766 | 1.00 | LMNA (0.65) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL19387345 | 0.98 | LMNA (0.62) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL12882141 | 0.95 | LMNA (0.59) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL21899665 | 0.93 | SMN1; SMN2 (0.57) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL2340586 | 0.92 | SMN1; SMN2 (0.55) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL28237074 | 0.91 | LMNA (0.54) | LMNAALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2078724-B1 | PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES | ASAHI CHEMICAL IND (JP) | 2016-11-30 | — | — | EP | disclosed |
| CN-104151162-B | Use the manufacture method of the carbonic ester of alkyltin alkoxides compound | 旭化成株式会社 | 2016-08-24 | — | — | CN | disclosed |
| CN-102112482-B | Method for producing alkyl tin alkoxide compound and method for producing carbonate ester using the same | ASAHI KASEI CHEMICALS CORP. (JP) | 2016-01-20 | — | — | CN | disclosed |
| CN-104151162-A | Process for production of alkyl tin alkoxide compound, and process for production of carbonate ester using the compound | ASAHI KASEI CHEMICALS CORP | 2014-11-19 | — | — | CN | disclosed |
| CN-101522697-B | Process for production of dialkyltin dialkoxides | ASAHI KASEI CHEMICALS CORP (JP) | 2013-05-29 | — | — | CN | disclosed |
| EP-2226328-B1 | PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND | ASAHI KASEI CHEMICALS CORP (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-8168812-B2 | Process for producing alkyl tin alkoxide compound and process for producing carbonic acid ester using said compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-8008518-B2 | Process for producing dialkyl tin dialkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| CN-102112482-A | Method for producing alkyl tin alkoxide compound and method for producing carbonate ester using the same | ASAHI CHEMICAL CORP | 2011-06-29 | — | — | CN | disclosed |
| US-20100292496-A1 | Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-2226328-A1 | PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND | Asahi Kasei Chemicals Corporation (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-20100041908-A1 | PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2078724-A1 | PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES | Asahi Kasei Chemicals Corporation (JP) | 2009-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041908-A1 | PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES | DEK, DDT, DERA | LMNA 4325/4885ALDH1A1 1422/4885TSHR 2537/4885 |
| US-20100292496-A1 | Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound | OXSR1, AOC2, OXER1 | LMNA 3334/4885ALDH1A1 1746/4885TSHR 249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.